Denosumab Versus Zoledronic Acid in Cases of Surgically Unsalvageable Giant Cell Tumor of Bone: A Randomized Clinical Trial
ConclusionsDenosumab is a safe but costly alternative to zoledronic acid for treatment of surgically unsalvageable giant cell tumor of bone.Graphical Abstract
Source: Journal of Bone Oncology - Category: Cancer & Oncology Source Type: research
More News: Back Pain | Cancer & Oncology | Clinical Trials | Pain | Reclast | Statistics | Xgeva | Zometa